Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece in the New Haven Register cited an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “First Case of COVID-19 Reinfection Detected in the US,” examined a man in Nevada who experienced the first reported case of coronavirus disease 2019 (COVID-19) reinfection in the United States and the fifth case of reinfection worldwide.
An article published in a November 2020 supplement to AJMC®, titled “Screening for Cancer: The Economic, Medical, and Psychosocial Issues,” highlighted the risks and benefits that government and managed care organizations should consider in seeking to improve health outcomes of patients with cancer. The article was spotlighted by docwirenews and UroToday.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More